Michael Peluso, Md
Clinical trials sponsored by Michael Peluso, Md, explained in plain language.
-
Could a single drug let HIV patients ditch daily meds?
Disease control ENROLLING_BY_INVITATIONThis study tests whether a drug called N-803 (IL-15) can boost the immune system to control HIV without daily antiretroviral therapy. 20 adults with well-controlled HIV will receive the drug or placebo, then temporarily stop their regular HIV meds to see if the virus stays suppre…
Phase: PHASE2 • Sponsor: Michael Peluso, MD • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
Could an antibody ease long COVID? new study investigates
Symptom relief OngoingThis study tests whether a lab-made antibody called AER002 can safely help people with Long COVID feel better. Researchers think that leftover virus pieces in the body might cause Long COVID, and this antibody aims to target them. The trial involves 36 adults who receive either t…
Phase: PHASE2 • Sponsor: Michael Peluso, MD • Aim: Symptom relief
Last updated May 26, 2026 06:44 UTC